{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:15:15Z","timestamp":1785942915287,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1097\/01.hjh.0000249698.26983.4e","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T15:24:57Z","timestamp":1161185097000},"page":"2207-2213","source":"Crossref","is-referenced-by-count":17,"title":["Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats"],"prefix":"10.1097","volume":"24","author":[{"given":"Anne","family":"Miternique-Grosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Griffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Weltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210208","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2796.2003.01297.x","article-title":"Manipulating angiogenesis in medicine","volume":"255","author":"Carmeliet","year":"2004","journal-title":"J Intern Med"},{"key":"R2-15-20210208","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","article-title":"Rationale for the use of aldosterone antagonists in congestive heart failure","volume":"62","author":"Rocha","year":"2002","journal-title":"Drugs"},{"key":"R3-15-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-15-20210208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11897-005-0011-5","article-title":"The risks and benefits of aldosterone antagonists","volume":"2","author":"Sica","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"R5-15-20210208","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","article-title":"New activity of spironolactone","volume":"94","author":"Klauber","year":"1996","journal-title":"Circulation"},{"key":"R6-15-20210208","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"R7-15-20210208","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"R8-15-20210208","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1016\/S0021-9258(18)51460-5","article-title":"Stimulation of the Na+\/H+ exchanger in human endothelial cells activated by granulocyte- and granulocyte-macrophage-colony-stimulating factor. Evidence for a role in proliferation and migration","volume":"264","author":"Bussolino","year":"1989","journal-title":"J Biol Chem"},{"key":"R9-15-20210208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.vph.2003.08.003","article-title":"Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells","volume":"40","author":"Chen","year":"2004","journal-title":"Vasc Pharmacol"},{"key":"R10-15-20210208","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1358\/mf.1999.21.7.550113","article-title":"Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits","volume":"21","author":"Sood","year":"1999","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"R11-15-20210208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1067\/mlc.2003.19","article-title":"A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances","volume":"141","author":"Hazel","year":"2003","journal-title":"J Lab Clin Med"},{"key":"R12-15-20210208","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N Engl J Med"},{"key":"R13-15-20210208","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"R14-15-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-1759(01)00404-5","article-title":"Sensitive determination of cell number using the CyQUANT\u00ae cell proliferation assay","volume":"254","author":"Jones","year":"2001","journal-title":"J Immunol Methods"},{"key":"R15-15-20210208","first-page":"3239","article-title":"A rapid in vitro assay for quantitating the invasive potential of tumor cells","volume":"47","author":"Albini","year":"1987","journal-title":"Cancer Res"},{"key":"R16-15-20210208","first-page":"287","article-title":"Quantitative image analysis of angiogenesis in rats implanted with a fibrin gel chamber","volume":"34","author":"Rohr","year":"1992","journal-title":"Nouv Rev Fr Hematol"},{"key":"R17-15-20210208","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.hjh.0000174607.18780.62","article-title":"Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in prehypertensive spontaneously hypertensive rats","volume":"23","author":"Hudlett","year":"2005","journal-title":"J Hypertens"},{"key":"R18-15-20210208","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis","volume":"267","author":"Folkman","year":"1992","journal-title":"J Biol Chem"},{"key":"R20-15-20210208","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1749-6632.2001.tb03526.x","article-title":"Role of fibrin matrix in angiogenesis","volume":"936","author":"Van Hinsbergh","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"R21-15-20210208","first-page":"H1620","article-title":"VEGF and bFGF stimulate myocardial vascularization in embryonic chick","volume":"274","author":"Tomanek","year":"1998","journal-title":"Am J Physiol"},{"key":"R22-15-20210208","first-page":"650","article-title":"Three new epoxy-spironolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-15-20210208","first-page":"521","article-title":"Eplerenone (G. D. Searle & Co)","volume":"2","author":"Martin","year":"2001","journal-title":"Curr Opin Invest Drugs"},{"key":"R24-15-20210208","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1524-6175.2004.03057.x","article-title":"The use of aldosterone receptor blockers in the treatment of hypertension","volume":"6","author":"Weinberger","year":"2004","journal-title":"J Clin Hypertens"},{"key":"R25-15-20210208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R26-15-20210208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jez.1402670302","article-title":"Amiloride inhibition of angiogenesis in vitro","volume":"267","author":"Alliegro","year":"1993","journal-title":"J Exp Zool"},{"key":"R27-15-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexcr.2004.05.008","article-title":"DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling","volume":"299","author":"Mamoune","year":"2004","journal-title":"Exp Cell Res"},{"key":"R28-15-20210208","first-page":"109","article-title":"Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride","volume":"17","author":"Jankun","year":"1999","journal-title":"Cancer Biochem Biophys"},{"key":"R29-15-20210208","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1083\/jcb.105.6.2535","article-title":"Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells","volume":"105","author":"Pepper","year":"1987","journal-title":"J Cell Biol"},{"key":"R30-15-20210208","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1242\/jcs.110.18.2293","article-title":"Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor","volume":"110","author":"Mandriota","year":"1997","journal-title":"J Cell Sci"},{"key":"R31-15-20210208","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000127112.36796.9B","article-title":"Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway","volume":"109","author":"Michel","year":"2004","journal-title":"Circulation"},{"key":"R32-15-20210208","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment","volume":"230","author":"Crum","year":"1985","journal-title":"Science"},{"key":"R33-15-20210208","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1139\/y03-066","article-title":"Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity","volume":"81","author":"Chen","year":"2003","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-200703000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:36:28Z","timestamp":1785940588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200611000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.hjh.0000249698.26983.4e","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}